Skip to main content

Iridex Corp

IRIX
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001006045

In the last 90 days, Iridex Corp insiders filed 4 open-market purchases and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $2.47M in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Iridex Corp changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of IRIX: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders32320
Shares3.51M3.68M+172.0K (+4.9%)
Value$21.4M$17.0M−$4.39M (−20.5%)

New holders (5)

Institutions that held Iridex Corp at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to IRIX in Q1 2022
InstitutionSharesValue% of portfolio
Millennium Management LLC19,299$89.0K0.00%
Mackenzie Financial Corp12,044$56.0K0.00%
JPMorgan Chase & Co3,601$17.0K0.00%
Advisor Group Holdings, Inc.1,000$5.00K0.00%
Simplex Trading, LLC450$2.00K0.00%

Sold out (5)

Institutions that held Iridex Corp at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of IRIX in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
Blair William & Co60,000$367.0K
Two Sigma Investments, LP15,100$92.0K
Total Clarity Wealth Management, Inc.989$6.00K
US Bancorp210$1.00K
Bank of America Corp17$0